Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira Jung

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Biological & Pharmaceutical Bulletin|January 6, 2009
Involvement of P-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cellsZacharoula Konsoula, Mira Jung
International Journal of Pharmaceutics|June 20, 2008
In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitorsRoula Konsoula, Mira Jung
The Journal of Biological Chemistry|March 21, 2007
The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activationSung A Lee, Mira Jung
Chemistry & Biodiversity|December 29, 2006
Rational design and development of radiation-sensitizing histone deacetylase inhibitorsMira Jung, Alan Kozikowski, Anatoly Dritschilo
Basic Research in Cardiology|December 8, 2018
Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarctionMira Jung, Michael Dodsworth, Thomas Thum
Current Topics in Medicinal Chemistry|April 10, 2009
Assays for histone deacetylasesAlexander-Thomas Hauser, Mira Jung, Manfred Jung
Molecular Cancer Therapeutics|October 1, 2009
Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitorsZacharoula Konsoula, Hong Cao, Alfredo Velena, et al.
Radiation Research|May 27, 2004
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitorsYin Zhang, Manfred Jung, Anatoly Dritschilo, et al.
Metalloproteinases in Medicine|July 5, 2016
Using the laws of thermodynamics to understand how matrix metalloproteinases coordinate the myocardial response to injuryRugmani Padmanabhan Iyer, Mira Jung, Merry L Lindsey
Plos One|July 15, 2024
Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growthMira Jung, Nicole Nicholas, Scott Grindrod, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Biological & Pharmaceutical Bulletin|January 6, 2009
Involvement of P-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cellsZacharoula Konsoula, Mira Jung
International Journal of Pharmaceutics|June 20, 2008
In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitorsRoula Konsoula, Mira Jung
The Journal of Biological Chemistry|March 21, 2007
The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activationSung A Lee, Mira Jung
Chemistry & Biodiversity|December 29, 2006
Rational design and development of radiation-sensitizing histone deacetylase inhibitorsMira Jung, Alan Kozikowski, Anatoly Dritschilo
Basic Research in Cardiology|December 8, 2018
Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarctionMira Jung, Michael Dodsworth, Thomas Thum
Current Topics in Medicinal Chemistry|April 10, 2009
Assays for histone deacetylasesAlexander-Thomas Hauser, Mira Jung, Manfred Jung
Molecular Cancer Therapeutics|October 1, 2009
Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitorsZacharoula Konsoula, Hong Cao, Alfredo Velena, et al.
Radiation Research|May 27, 2004
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitorsYin Zhang, Manfred Jung, Anatoly Dritschilo, et al.
Metalloproteinases in Medicine|July 5, 2016
Using the laws of thermodynamics to understand how matrix metalloproteinases coordinate the myocardial response to injuryRugmani Padmanabhan Iyer, Mira Jung, Merry L Lindsey
Plos One|July 15, 2024
Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growthMira Jung, Nicole Nicholas, Scott Grindrod, et al.
Pageof 9